{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:26:20Z","timestamp":1715041580681},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41440-024-01590-1","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T10:02:19Z","timestamp":1707213739000},"page":"1231-1234","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of preterm preeclampsia risk in Asians using a simple two-item assessment in early pregnancy"],"prefix":"10.1038","volume":"47","author":[{"given":"Seiya","family":"Izumi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Iwama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohito","family":"Metoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"key":"1590_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","volume":"387","author":"BWJ Mol","year":"2016","unstructured":"Mol BWJ, Roberts CT, Thangaratinam S, Magee LA, De Groot CJM, Hofmeyr GJ. Pre-eclampsia. Lancet. 2016;387:999\u20131011.","journal-title":"Lancet"},{"key":"1590_CR2","first-page":"1","volume":"30","author":"G Grau","year":"2010","unstructured":"Grau G. The two stage model of preeclampsia: variations on the theme. NIH Public Access. 2010;30:1\u201312.","journal-title":"NIH Public Access"},{"key":"1590_CR3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physiol.00043.2008","volume":"24","author":"A Wang","year":"2009","unstructured":"Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24:147\u201358.","journal-title":"Physiology"},{"key":"1590_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","volume":"374","author":"H Zeisler","year":"2016","unstructured":"Zeisler H, Llurba E, Chantraine F, Vatish M, Staff AC, Sennstr\u00f6m M, et al. Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med. 2016;374:13\u201322.","journal-title":"N Engl J Med"},{"key":"1590_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000341264","volume":"33","author":"R Akolekar","year":"2013","unstructured":"Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013;33:8\u201315.","journal-title":"Fetal Diagn Ther"},{"key":"1590_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for Preterm preeclampsia. N Engl J Med. 2017;377:613\u201322.","journal-title":"N Engl J Med"},{"key":"1590_CR7","doi-asserted-by":"publisher","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","volume":"226","author":"DL Rolnik","year":"2022","unstructured":"Rolnik DL, Nicolaides KH, Poon LC. Prevention of preeclampsia with aspirin. Am J Obstet Gynecol. 2022;226:S1108\u201319.","journal-title":"Am J Obstet Gynecol"},{"key":"1590_CR8","doi-asserted-by":"publisher","first-page":"101827","DOI":"10.1016\/j.jogoh.2020.101827","volume":"50","author":"M Mendoza","year":"2021","unstructured":"Mendoza M, Tur H, Garcia-Manau P, Hurtado I, Serrano B, Lopez-Martinez RM, et al. Cut-off values for Gaussian first-trimester screening for early-onset preeclampsia with maternal history, biochemical markers and uterine artery Doppler. J Gynecol Obstet Hum Reprod. 2021;50:101827.","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"1590_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1001\/jama.2023.0691","volume":"329","author":"M Mendoza","year":"2023","unstructured":"Mendoza M, Bonacina E, Garcia-Manau P, L\u00f3pez M, Caami\u00f1a S, Vives \u00c0, et al. Aspirin discontinuation at 24 to 28 weeks\u2019 gestation in pregnancies at high risk of preterm preeclampsia: a randomized clinical trial. JAMA. 2023;329:542\u201350.","journal-title":"JAMA"},{"key":"1590_CR10","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1161\/HYPERTENSIONAHA.119.12760","volume":"74","author":"X Bian","year":"2019","unstructured":"Bian X, Biswas A, Huang X, Lee KJ, Li TKT, Masuyama H, et al. Short-term prediction of adverse outcomes using the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor) ratio in Asian women with suspected preeclampsia. Hypertension. 2019;74:164\u201372.","journal-title":"Hypertension"},{"key":"1590_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41440-021-00629-x","volume":"44","author":"A Ohkuchi","year":"2021","unstructured":"Ohkuchi A, Saito S, Yamamoto T, Minakami H, Masuyama H, Kumasawa K, et al. Short-term prediction of preeclampsia using the sFlt-1\/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study. Hypertens Res. 2021;44:813\u201321.","journal-title":"Hypertens Res"},{"key":"1590_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.14390\/jsshp.HRP2020-009","volume":"8","author":"A Ohkuchi","year":"2020","unstructured":"Ohkuchi A, Kondoh E, Yamamoto T, Seki H, Saito S, Makino S, et al. Expert consensus: indication criteria and screening strategy for preeclampsia using the serum sFlt-1\/PlGF ratio at 18\u201336 weeks of gestation in women at imminent\/basal risk of preeclampsia under insurance coverage. Hypertens Res Pregnancy. 2020;8:51\u20136.","journal-title":"Hypertens Res Pregnancy"},{"key":"1590_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41440-020-00571-4","volume":"44","author":"M Goto","year":"2021","unstructured":"Goto M, Koide K, Tokunaka M, Takita H, Hamada S, Nakamura M, et al. Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11\u201313 weeks of gestation in a Japanese population. Hypertens Res. 2021;44:685\u201391.","journal-title":"Hypertens Res"},{"key":"1590_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.preghy.2019.06.004","volume":"17","author":"YKY Cheng","year":"2019","unstructured":"Cheng YKY, Poon LCY, Shennan A, Leung TY, Sahota DS. Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor. Pregnancy Hypertens. 2019;17:165\u201371.","journal-title":"Pregnancy Hypertens"},{"key":"1590_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/jch.14606","volume":"25","author":"H Ohseto","year":"2023","unstructured":"Ohseto H, Ishikuro M, Obara T, Murakami K, Onuma T, Noda A, et al. Dietary calcium intake was related to the onset of pre-eclampsia: the TMM BirThree cohort study. J Clin Hypertens. 2023;25:61\u201370.","journal-title":"J Clin Hypertens"},{"key":"1590_CR16","doi-asserted-by":"publisher","unstructured":"Ohkuchi A, Takahashi K, Hirashima C, Takahashi H, Nagayama S, Ogoyama M, et al. Automated electrochemiluminescence immunoassay for serum PlGF levels in women with singleton pregnancy at 9-13 weeks of gestation predicts preterm preeclampsia: a retrospective cohort study. Hypertens Res. 2023. https:\/\/doi.org\/10.1038\/s41440-023-01534-1.","DOI":"10.1038\/s41440-023-01534-1"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01590-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01590-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01590-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:03:40Z","timestamp":1715036620000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-024-01590-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["1590"],"URL":"https:\/\/doi.org\/10.1038\/s41440-024-01590-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"23 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interests (COIs) for this Comment article. However, the following funding may represent potential COI: Grants for Scientific Research (24689061, 16H05243, and 19H03905) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Grant-in-Aid (19DA1001) for Health Research on Children, Youth, and Families and H21-Junkankitou (Seishuu)-Ippan-004 from the Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan; and a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) fellows (19.7152). Additionally, academic contributions were received from Pfizer Japan Inc., Bayer Academic Support; Takeda Research Support, Astellas Research Support, and J&J Medical Research Grant, and scholarship donations were received from Chugai Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Otsuka Pharmaceutical Co., Ltd. HM concurrently holds a noncompensated subdirectorship position at the Tohoku Institute for Management of Blood Pressure, which is supported by Omron Health Care Co. Ltd.; HM is involved in collaborative research with Omron Health Care in another study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}